Table 3.
Group (n) | VEGF (ng/L) | IL-1β (ng/L) | TNF-α (ng/L) | |||
---|---|---|---|---|---|---|
| ||||||
Week 4 | Week 8 | Week 4 | Week 8 | Week 4 | Week 8 | |
Group A (n) | 59.0 ± 5.1 | 59.5 ± 6.3 | 16.3 ± 4.2 | 16.8 ± 5.1 | 16.6 ± 5.3 | 18.2 ± 6.0 |
Group B (n) | 81.3 ± 6.0a | 84.5 ± 7.1a | 31.2 ± 5.1a | 31.5 ± 4.2a | 38.7 ± 6.0a | 38.4 ± 5.1a |
Group C (n) | 98.3 ± 7.1a,b,c | 104.3 ± 5.8a,b,c | 23.3 ± 4.2a,b,c | 23.8 ± 3.8a,b,c | 24.3 ± 4.8a,b,c | 24.5 ± 6.7a,b,c |
Group D (n) | 90.1 ± 5.1a,c | 92.3 ± 6.1a,c | 27.1 ± 4.1a,c | 27.7 ± 4.4a,c | 31.1 ± 5.8a,c | 32.8 ± 6.0a,c |
compared with group A, P < 0.05;
compared with group D, P < 0.05;
compared with group B, P < 0.05.